Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla, ITGB1, Fibrinogen Receptor beta Subunit, FNRB, Integrin VLA4 Subunit beta, MDF2, MSK12, Very Late Activation Protein beta Polypeptide, VLAB, VLAbeta) (FITC)

Product Sizes
0.1 mg
£ POA
MBS632355-0.1MG
About this Product
SKU:
MBS632355
Additional Names:
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); Integrin, beta 1 (Fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); integrin beta-1; OTTHUMP00000019420; integrin VLA-4 beta subunit; very late activation protein, beta polypeptide; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); Anti -Integrin, beta1 (CD29, Very Late Antigen, VLAb1, Platelet gplla, ITGB1, Fibrinogen Receptor beta Subunit, FNRB, Integrin VLA4 Subunit beta, MDF2, MSK12, Very Late Activation Protein beta Polypeptide, VLAB, VLAbeta) (FITC)
Application:
FACS, Flow Cytometry, Western Blot
translate.label.attr.clone:
[6A561]
Clonality:
Monoclonal
Host:
Mouse
Isotype:
IgG1
Physical State:
Supplied as a liquid in PBS, 1% BSA, 0.02% sodium azide. Labeled with fluorescein isothiocyanate (FITC).
Purity:
Affinity Purified Purified.
Reactivities:
Human
Shipping Conditions:
Blue Ice
Specificity:
Recognizes human beta1 integrin chain present on tumor cells. Active on HT-29 colon carcinoma cells and on HCCP-2998 tumor cells. Binds to several other tumor cells (MG3 osteosarcoma, A375 melanoma, MHCC-1410 and Lovo colon carcinoma) but does not affect adhesion to endothelial cells.
Storage Conditions:
Please refer to datasheet
Supplier:
MyBioSource
Type:
Antibody: Monoclonal Antibody
Price enquiry form